TD Cowen Maintains Outperform on Agilon Health, Lowers Price Target to $25
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Gary Taylor maintains an Outperform rating on Agilon Health (NYSE:AGL) but lowers the price target from $29 to $25.
August 15, 2023 | 12:31 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
TD Cowen analyst Gary Taylor maintains an Outperform rating on Agilon Health but lowers the price target from $29 to $25.
The news is directly related to Agilon Health (AGL). While the Outperform rating is maintained, the lowering of the price target from $29 to $25 might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100